Related Articles

News
STAT+: Pharmalittle: Cancer drug trial yields remission in every patient; Novartis data hacked by extortionists
June 6, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Pharmalittle: Cancer drug trial yields remission in every patient; Novartis data hacked by extortionists
In results called unprecedented, an experimental GSK treatment shrank locally advanced rectal cancer until it was undetectable in all 14 patients in a clinical trial. […]

News
Opinion: STAT+: How digital health innovators can successfully navigate evolving FDA regulations
October 19, 2022
San Francisco Biotechnology Network News
News
Comments Off on Opinion: STAT+: How digital health innovators can successfully navigate evolving FDA regulations
Pursuing a regulated path has some associated time and financial costs. Yet it can be foundational to securing funding from investors, establishing reimbursement pathways with payers, and more. […]

News
STAT+: Gilead wins a key battle with the CDC over patents for its Truvada HIV pill
December 2, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Gilead wins a key battle with the CDC over patents for its Truvada HIV pill
The judge noted the CDC did not alert Gilead to a patent on Truvada until 2016, one year after it had been issued. […]